Since pancreatic cancer cells are well known to overexpress TGF-β, which has a prominent-role in inducing EMT, the expression of TGF-β in the pancreatic cell lines was investigated following the treatment with rfhSP-D (20 μg/ml). This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.